[Form 4] Regional Health Properties, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Paul Jason O'Sullivan, Senior Vice President of Regional Health Properties, Inc. (RHE) reported changes in his beneficial ownership on a Form 4. The filing shows a disposition of 51,130 shares of common stock (reported as D) and three purchase transactions: 10,600 shares on 08/18/2025 at a weighted average $1.85, 5,600 shares on 08/19/2025 at a weighted average $1.92, and 3,800 shares on 08/20/2025 at $1.80. After these purchases the reporting person beneficially owns 33,500 shares indirectly (noted "By IRA"). The filing includes explanatory notes that the reported purchase prices are weighted averages from multiple trades.

Positive

• Insider purchases recorded: 10,600 shares on 08/18/2025 at $1.85 (weighted average), 5,600 shares on 08/19/2025 at $1.92 (weighted average), and 3,800 shares on 08/20/2025 at $1.80, totaling 20,000 shares acquired
• Final beneficial ownership disclosed: 33,500 shares reported indirectly ("By IRA") after the transactions
• Disclosure includes weighted-average price explanations: The filer offers to provide trade-breakdowns on request, increasing transparency

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider sold 51,130 shares then acquired 20,000 shares across three trades, ending with 33,500 shares held indirectly.

The Form 4 documents a net change in reported position driven by a large disposition followed by smaller purchases recorded over three days. The purchases total 20,000 shares at weighted-average prices between $1.80 and $1.92, and the final reported beneficial ownership is 33,500 shares held indirectly in an IRA. This is a routine Section 16 disclosure showing both disposals and acquisitions; the filing provides weighted-average price disclosures for aggregated trades.

Corporate Governance Expert

TL;DR: Form 4 is a standard insider-reporting disclosure showing a mix of sale and subsequent purchases, filed and signed by the reporting person.

The filing identifies the reporting person as Senior Vice President and indicates the transactions were reported under the applicable rules with explanatory notes on price averaging. The ownership is reported as indirect (By IRA) following the purchases. Documentation appears complete for Section 16 reporting: transaction dates, codes, quantities, and weighted-average prices are provided, and the form is signed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'sullivan Paul Jason

(Last) (First) (Middle)

C/O REGIONAL HEALTH PROPERTIES, INC

1050 CROWN POINTE PARKWAY SUITE 720

(Street)

ATLANTA GA 30338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHEP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								51,130	D
Common Stock	08/18/2025		P		10,600	A	$1.85(1)	24,100	I	By IRA
Common Stock	08/19/2025		P		5,600	A	$1.92(2)	29,700	I	By IRA
Common Stock	08/20/2025		P		3,800	A	$1.8	33,500	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $1.67 and $1.97. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

2. This transaction was executed in multiple trades at prices ranging from $1.83 and $2.00. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Paul Jason O'Sullivan	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Paul Jason O'Sullivan report on Form 4 for RHE?

The Form 4 reports a disposition of 51,130 shares and three purchases totaling 20,000 shares on 08/18/2025, 08/19/2025, and 08/20/2025.

How many RHE shares does the reporting person beneficially own after these transactions?

The filing reports 33,500 shares beneficially owned following the reported transactions, held indirectly (By IRA).

What prices were paid for the purchased RHE shares?

The filing reports weighted-average prices: $1.85 for 08/18/2025 purchases, $1.92 for 08/19/2025 purchases, and $1.80 for 08/20/2025 purchases; explanatory notes state trades occurred at ranges around those averages.

What is the reporting person's role at Regional Health Properties, Inc.?

The Form 4 identifies the reporting person as Senior Vice President and an officer of the issuer.

Did the filer provide additional details about trade pricing?

Yes. The filer stated each reported price is a weighted average from multiple trades and offered to provide full breakdowns upon request.